Reduction of ZDHHC2 expression was observed in 44.7% (211/472) of gastric adenocarcinoma patients, and was associated significantly with lymph node metastasis (p<0.001) and histological grade (p<0.001). Here, ZDHHC2 is linked to metastatic malignant neoplasm in the lymph nodes.